Related Experiment Video
Updated: Jul 9, 2026

06:08
Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
TNF-alpha and adipocyte biology.
William P Cawthorn1, Jaswinder K Sethi
1Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK.
FEBS Letters
|November 27, 2007
Summary
Tumor necrosis factor-alpha (TNF-alpha) disrupts adipose tissue function, contributing to metabolic disorders like obesity and diabetes. This review details how TNF-alpha impairs fat tissue
Area of Science:
- Metabolic research
- Adipose tissue biology
- Inflammation and metabolism
Background:
- Dyslipidemia and insulin resistance are linked to catabolic and obesity-related conditions.
- Adipose tissue dysfunction and elevated tumor necrosis factor-alpha (TNF-alpha) are common features.
- TNF-alpha is a pro-inflammatory adipokine with significant metabolic impact.
Purpose of the Study:
- To review the diverse actions of TNF-alpha on adipose tissue.
- To elucidate TNF-alpha's role in metabolic dysregulation.
- To discuss the molecular mechanisms underlying TNF-alpha's effects.
Main Methods:
- Literature review of TNF-alpha's functions in adipose tissue.
- Analysis of TNF-alpha's impact on key metabolic pathways.
- Examination of TNF-alpha's influence on adipose tissue endocrine functions.
Main Results:
- TNF-alpha inhibits carbohydrate metabolism, lipogenesis, adipogenesis, and thermogenesis.
- TNF-alpha stimulates lipolysis in adipose tissue.
- Impaired adipose tissue function and fuel storage contribute to metabolic dysregulation.
Conclusions:
- TNF-alpha significantly contributes to metabolic disorders by disrupting adipose tissue homeostasis.
- Understanding TNF-alpha's mechanisms is crucial for addressing dyslipidemia and insulin resistance.
- Targeting TNF-alpha may offer therapeutic strategies for metabolic diseases.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

